Topic
Product Liability
2,986 published works
Drug & Device Law
Dismissal of Negligent Undertaking Claim in Massachusetts
By Eric Hudson
Today’s opinion, Digan v. Luxco, Inc., 2026 U.S. Dist. LEXIS 209391 (D. Mass. Sept. 16, 2026), arises from the bad combination of an open flame, a fraternity party, and Everclear…
Stritmatter Law Blog
Parents File Lawsuit Against Amazon for Dangerous Laser Pointer
By Publisher
For Immediate Release An Idaho family has retained Stritmatter Law to file a lawsuit against Amazon and the manufacturers of a dangerous laser pointer sold on the site. The Lennoos…
Product Perspective: Complex Tort & Product Law
Autonomous Vehicles: The Road Ahead for Product Liability
By Kate Dickenson, Ciara Harper, Luke Hemmerla
The U.S. Department of Transportation estimates that millions of Americans are injured in motor vehicle crashes annually.1 In just 2025, an estimated 36,640 Americans died as a result of a…
Drug & Device Law
Lost In Translation
By Lisa Baird
Having clerked for a federal district judge and cut our litigation teeth in MDLs, federal court practice has burrowed deep. When we think of procedural issues, our brains reflexively think…
Drug & Device Law
N.D. Cal. Dismisses Device Claim for Lack of Defect
Perez v. Apyx Medical Corp., 2026 WL 2691359 (N.D. Cal. Sept. 14, 2026), is a product liability suit alleging misrepresentations about off-label use of a company’s cosmetic surgery §510(k) device.…
Drug Injury Watch
NAION News Reports: GLP-1 Side Effect Harms Vision, Eyes
By Tom Lamb
Ozempic, Wegovy, Mounjaro, Zepbound Associated With Loss of Eyesight (Posted by Tom Lamb at Drug Injury Watch) Non-arteritic anterior ischemic optic neuropathy (NAION) is a GLP-1 side effect that harms vision by causing…
Marler Blog
Target Denies Responsibility, But We Are Doing All We Can to Protect Babies Against the Next Botulism Outbreak
By Bill Marler
Last Friday, Target told a federal court that it had no duty to ask a single question about the infant formula it sold – even in the middle of a national infant…
Drug & Device Law
Let the Science Do the Science – S.D.N.Y Torches Every Benzene Theory in OTC Acne MDL
We’ve written a lot of benzene posts on this blog over the years, and most of them share a common thread. Plaintiffs find a chemical decomposition byproduct nobody put on…
Drug & Device Law
California’s Recent Gilead Decision Explains Why “Pre-Approval” Tort Claims Don’t, and Shouldn’t, Exist
By Bexis
Nearly a decade ago we published the blogpost “Pre-Approval Design Defects – No Such Thing.” As we discussed, “pre-approval” design (later joined by warning) claims were a transparent preemption dodge. …
The State AG Report
Abbott Laboratories Agrees to Pay Over $384 Million Settlement Over Powder Infant Formula Allegations
The post Abbott Laboratories Agrees to Pay Over $384 Million Settlement Over Powder Infant Formula Allegations appeared first on The State AG Report.